Drug Catalog - Product Detail
BETHANECHOL CHLORIDE TABS 25MG 100CT
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 64980-0162-01 | RISING PHARMACEUTICALS | 100 | 25MG | TABLET |
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION Bethanechol chloride, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related to acetylcholine. It is designated chemically as 2-[(aminocarbonyl)oxy]- N, N, N -trimethyl-1-propanaminium chloride. Its molecular formula is C 7 H 17 CIN 2 O 2 and its structural formula is: It is a white, hygroscopic crystalline powder having a slight amine-like odor, freely soluble in water, and has a molecular weight of 196.68. Each tablet for oral administration contains 5 mg, 10 mg, 25 mg or 50 mg bethanechol chloride, USP. Tablets also contain the following inactive ingredients: lactose monohydrate, silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, and povidone. bethanechol-struc
How Supplied
HOW SUPPLIED Bethanechol ChlorideTablets USP 5 mg – White, round, scored tablets in bottles of 100. Debossed EP 118 on one side and plain on reverse side. NDC 64980-160-01 Bottles of 100 10 mg – White, round, scored tablets in bottles of 100. Debossed EP 119 on one side and plain on reverse side. NDC 64980-161-01 Bottles of 100 25 mg – White, round, scored tablets in bottles of 100. Debossed EP 120 on one side and plain on reverse side. NDC 64980-162-01 Bottles of 100 50 mg -White, round, scored tablets in bottles of 100. Debossed EP 121 on one side and plain on reverse side. NDC 64980-163-01 Bottles of 100 Dispense in a tight container as defined in the USP. Store at 20°-25°C (68°-77°F) [See USP Controlled Room Temperature]. Manufactured for: Rising Pharmaceuticals, Inc. Allendale, NJ 07401 Manufactured by: Heritage Pharma Labs Inc. East Brunswick, NJ 08816 51U000000056US02 Revised: 08/2015 bethanechol-logo
Indications & Usage
INDICATIONS AND USAGE Bethanechol chloride is indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.
Dosage and Administration
DOSAGE AND ADMINISTRATION Dosage must be individualized, depending on the type and severity of the condition to be treated. Preferably give the drug when the stomach is empty. If taken soon after eating, nausea and vomiting may occur. The usual adult oral dose ranges from 10 to 50 mg three or four times a day. The minimum effective dose is determined by giving 5 to 10 mg initially, and repeating the same amount at hourly intervals until satisfactory response occurs, or until a maximum of 50 mg has been given. The effects of the drug sometimes appear within 30 minutes, and are usually maximal within 60 to 90 minutes. The drug effects persist for about one hour. If necessary, the effects of the drug can be abolished promptly by atropine (see OVERDOSAGE ).